1. Home
  2. PMTS vs SGMO Comparison

PMTS vs SGMO Comparison

Compare PMTS & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$13.89

Market Cap

152.4M

Sector

Finance

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.37

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMTS
SGMO
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.4M
141.2M
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
PMTS
SGMO
Price
$13.89
$0.37
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$27.67
$5.75
AVG Volume (30 Days)
73.8K
4.3M
Earning Date
03-05-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.89
EPS
1.25
N/A
Revenue
$312,189,000.00
$36,567,000.00
Revenue This Year
$9.09
$4.79
Revenue Next Year
$6.79
N/A
P/E Ratio
$11.11
N/A
Revenue Growth
12.27
88.60
52 Week Low
$10.81
$0.35
52 Week High
$30.51
$0.93

Technical Indicators

Market Signals
Indicator
PMTS
SGMO
Relative Strength Index (RSI) 49.34 42.57
Support Level $12.26 $0.36
Resistance Level $16.38 $0.56
Average True Range (ATR) 1.08 0.03
MACD 0.01 -0.00
Stochastic Oscillator 32.78 12.09

Price Performance

Historical Comparison
PMTS
SGMO

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: